SQSTM1 and cancer: Knockdown of autophagic genes involved in mitochondrial clearance, including BNIP3L/Nix and SQSTM1/p62 also sensitizes cells to mitochondria-targeted therapies [152, 153], arguing that these genes promote cancer cell survival.